In the run-up to CES 2022, I was chatting with Movano CEO John Mastrototaro about his big, ambitious idea for a smart ring that would one day monitor chronic illnesses. The renders showcased a sleek and slim ring with an open gap up top. It would be designed with women in mind. Accuracy would be paramount, and eventually, the ring would have FDA clearance as a medical device. It was an impressive pitch. It would just have to make it off the show floor.
A little over two years later, I now…
